While I don't take a lot of issue with your post I do firmly feel the $7 target 'in a few months' is overly pessimistic. News next week or in early April on DE2 alone should move price over $6 and anythiing positive on DE3 over $7 maybe over $8. Now just maybe in a 'few months' we'll have some testing of the then market price and $7 might be the 'bottom' that's tested.

It's not unlikely that in 'a few months' with news coming in from other players along with more from Noront the share price will be testing $10 rather than $7. Of course it all depends on exploration results BUT Noront is pulling out all the stops on this exploration and spending what it takes to get results. Given the money available for exploration and rich targets it seem more likely that $10 rather than $7 will be normal trading range.

Results (assays) that allow analysts to crunch some numbers would likely result in some BUY recommendations with target price by end of year much higher than $10 which should really bring in new buyers.